Friday, December 5, 2025

Latest

Jushi Acquires Vireo’s Pennsylvania Cultivation Assets, Announces Secured Financing

It appears that Vireo Health (CSE: VREO) is in the process of selling off assets. It was announced this morning that Jushi Holdings (CSE: JUSH) will be acquiring the firms Pennsylvania Medical Solutions, LLC, the operator of a 90,000 square production facility with 45,000 square feet of indoor cultivation.

The facility can accommodate a further 25,000 square feet of production if needed, while there is also an ongoing expansion underway at the property to increase cultivation from 20,000 square feet to 45,000 by mid-year. Once completed, the facility is anticipated to produce 800 to 1,000 pounds of dried flower a month.

Under the terms of the transaction, Jushi will pay US$16.3 million in cash for 100% equity in what they refer to as the “permittee”. A US$3.8 million seller note will also be issued in connection with the sale, along with the assumption of a US$17 million facility with a long-term lease obligation. No equity will be issued in connection with Jushi’s purchase.

Jushi will also obtain an option to acquire a 100% interest in Pennsylvania Dispensary Solutions, LLC in connection with the offer, a permitee for dispensary operations in the Northeast region of the state.

Subsequently, Jushi also announced a US$15.25 million financing via the issuance of senior secured notes bearing interest at 10% per annum, along with subordinate voting share warrants. The notes are to mature January 15, 2023. Warrant coverage is to amount to 75% of the offering, with any warrants issued having an expiry of December 23, 2024 and an exercise price of US$1.25 (C$1.70).

US$15.0 million of the offering will be utilized to purchase the Pennsylvania facility, with interest having been shown for up to an additional $10 million in financing.

The financing is to close in connection with the asset purchase from Vireo, which is anticipated to occur by the end of August 2020.

Lastly, Jushi also reaffirmed its 2021 revenues guidance of $200 to $250 million, with more details to be provided on the closing of the Pennsylvania asset purchase.

Jushi Holdings last traded at $1.75 on the CSE.


Information for this briefing was found via Sedar, Jushi Holdings and Vireo Health. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Copper Is Heading To $30 And Silver To $200 | Craig Parry

Mako Mining Q3 Earnings: The Transitional Quarter

B2Gold Q3 Earnings: Goose Troubles Cloud The Narrative

Recommended

Emerita Resources Awards Contract For Pre-Feasibility Study On Iberian Belt West Project

Selkirk Copper Appoints Two Members Of Selkirk First Nation To Leadership Team

Related News

Jushi Holdings Closes Debt Financing of US$45.21 Million

Jushi Holdings Inc. (CSE: JUSH) has announced the closing of its debt financing, with proceeds...

Friday, January 31, 2020, 12:13:21 PM

Jushi Holdings Raises Q4 Revenue Guidance, Announces Overnight Marketed Offering

Jushi Holdings (CSE: JUSH) has revised its fourth quarter 2020 guidance while announcing an overnight...

Monday, January 4, 2021, 05:34:19 PM

Jushi Holdings To Acquire Nevada-Based NuLeaf For US$62.5 Million

Jushi Holdings (CSE: JUSH) announced today that it has entered into an agreement to acquire Nevada-based...

Wednesday, November 17, 2021, 04:40:00 PM

Jushi Reports Q1 2021 Revenue Of US$41.7 Million, $26.1 Million Net Loss

Jushi Holdings Inc. (CSE: JUSH) released its Q1 2021 financial results this morning, highlighting quarterly...

Friday, May 28, 2021, 09:12:46 AM

Jushi Sees CFO Depart After Less Than A Year, Looks To Enforce Non-Compete

Jushi Holdings (CSE: JUSH) has seen its chief financial officer leave the company in search...

Wednesday, July 13, 2022, 09:40:11 AM